Hard to Treat Diseases (HTDS)

[abracky]

Two things. Shinn capital has the Rights to Tubercin, just like they always did. Shinn Capital sublicensed those rights to HTDS and T-19. That's the Share Exchange Agreement (SEA) that everyone is talking about. Shinn argued that it never closed and so was not binding. HTDS was arguing that it DID close. We won. It DID close.


What does this mean? It means that things go back to the way they were before the Shinn tried to hump us. Shinn Capital owns the rights to Tubercin and HTDS has the sublicensed rights to Tubercin from Shinn Capital.

HTDS gets to market tubercin